POSTER: ABCL-817 Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
Jessica Chicola(Memorial Sloan Kettering Cancer Center), Pallawi Torka(Roswell Park Comprehensive Cancer Center), Monica Masterson(Institute of Cancer Research), Yazeed Sawalha(Cleveland Clinic), Alex F. Herrera(City of Hope), Muhamad Alhaj Moustafa(Jacksonville College), David A. Russler‐Germain(Washington University in St. Louis), Allison M. Bock(Mayo Clinic), Benjamin Heyman(Fleet Science Center), Michelle Okwali(Memorial Sloan Kettering Cancer Center), Joanna Rhodes(Roswell Park Comprehensive Cancer Center), Varun Iyengar(Kettering University), Vincenzo J. Pizzuti(University of Colorado Cancer Center), Michele Stanchina(Sylvester Comprehensive Cancer Center), Ajay Major(University of Colorado Cancer Center), Jefferson Parker, Talal Hilal(WinnMed), Stacy Pak(City Of Hope National Medical Center), Nicole Birrer(University of Utah), Danielle Wallace(Institute of Cancer Research), Chaitra S. Ujjani(Fred Hutch Cancer Center), Youssef Youssef(The Ohio State University), Jennifer L. Crombie(Dana-Farber Cancer Institute), Lu Chen(National Clinical Research), Yucai Wang(Mayo Clinic), Seth Buller(City Of Hope National Medical Center), Jomel Meeko Manzano(City Of Hope National Medical Center), Ahmed Bahnasy(TOCA at Banner Health), Patrick Gould(Kettering University), Christine Goth(City Of Hope National Medical Center), Peter A. Riedell(University of Chicago), Adrienne Nadved, Hua‐Jay J. Cherng
Cited by 0
Related Papers
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
|JAMA Oncology|2019|829
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
|New England Journal of Medicine|2022|457
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
|Journal of Oncology Practice|2017|447